

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of hippo signaling (GO:0035330) | 5.13440937 |
| 2 | hemidesmosome assembly (GO:0031581) | 4.03468682 |
| 3 | regulation of cholesterol homeostasis (GO:2000188) | 4.02078723 |
| 4 | desmosome organization (GO:0002934) | 3.98051783 |
| 5 | lysine catabolic process (GO:0006554) | 3.76499240 |
| 6 | lysine metabolic process (GO:0006553) | 3.76499240 |
| 7 | 4-hydroxyproline metabolic process (GO:0019471) | 3.58950735 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.58063967 |
| 9 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.50413999 |
| 10 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.46568712 |
| 11 | alpha-linolenic acid metabolic process (GO:0036109) | 3.44068250 |
| 12 | valine metabolic process (GO:0006573) | 3.40412338 |
| 13 | 2-oxoglutarate metabolic process (GO:0006103) | 3.40302768 |
| 14 | macroautophagy (GO:0016236) | 3.39164368 |
| 15 | regulation of cell proliferation involved in kidney development (GO:1901722) | 3.39151898 |
| 16 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.37008910 |
| 17 | intestinal cholesterol absorption (GO:0030299) | 3.36146231 |
| 18 | cellular ketone body metabolic process (GO:0046950) | 3.31348022 |
| 19 | cellular response to ATP (GO:0071318) | 3.30636091 |
| 20 | phospholipid homeostasis (GO:0055091) | 3.24956342 |
| 21 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.23921148 |
| 22 | protein carboxylation (GO:0018214) | 3.23921148 |
| 23 | regulation of triglyceride catabolic process (GO:0010896) | 3.18919419 |
| 24 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.18211113 |
| 25 | L-phenylalanine catabolic process (GO:0006559) | 3.18211113 |
| 26 | negative regulation of fibrinolysis (GO:0051918) | 3.17554042 |
| 27 | positive regulation of histone deacetylation (GO:0031065) | 3.15532306 |
| 28 | kynurenine metabolic process (GO:0070189) | 3.15402223 |
| 29 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.15088032 |
| 30 | L-phenylalanine metabolic process (GO:0006558) | 3.15088032 |
| 31 | urea cycle (GO:0000050) | 3.11403062 |
| 32 | urea metabolic process (GO:0019627) | 3.11403062 |
| 33 | low-density lipoprotein particle clearance (GO:0034383) | 3.09816266 |
| 34 | negative regulation of TOR signaling (GO:0032007) | 3.08651976 |
| 35 | endosome to melanosome transport (GO:0035646) | 3.07850877 |
| 36 | endosome to pigment granule transport (GO:0043485) | 3.07850877 |
| 37 | intestinal absorption (GO:0050892) | 3.06202859 |
| 38 | COPI coating of Golgi vesicle (GO:0048205) | 3.04104007 |
| 39 | Golgi transport vesicle coating (GO:0048200) | 3.04104007 |
| 40 | behavioral response to nicotine (GO:0035095) | 3.03427493 |
| 41 | negative regulation of mast cell activation (GO:0033004) | 3.03185314 |
| 42 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.02117468 |
| 43 | negative regulation of sterol transport (GO:0032372) | 3.01197267 |
| 44 | negative regulation of cholesterol transport (GO:0032375) | 3.01197267 |
| 45 | fatty acid transmembrane transport (GO:1902001) | 3.00241994 |
| 46 | protein localization to endosome (GO:0036010) | 3.00016469 |
| 47 | white fat cell differentiation (GO:0050872) | 2.99419611 |
| 48 | high-density lipoprotein particle remodeling (GO:0034375) | 2.98226008 |
| 49 | carnitine shuttle (GO:0006853) | 2.97076975 |
| 50 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.95225657 |
| 51 | oxaloacetate metabolic process (GO:0006107) | 2.93422823 |
| 52 | cellular modified amino acid catabolic process (GO:0042219) | 2.92047558 |
| 53 | positive regulation of nuclease activity (GO:0032075) | 2.91878939 |
| 54 | regulation of tight junction assembly (GO:2000810) | 2.91369575 |
| 55 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.90226505 |
| 56 | negative regulation of protein localization to cell surface (GO:2000009) | 2.89040186 |
| 57 | positive regulation of lipid catabolic process (GO:0050996) | 2.87101220 |
| 58 | ketone body metabolic process (GO:1902224) | 2.86883498 |
| 59 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.85909913 |
| 60 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.85347606 |
| 61 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.85243011 |
| 62 | cysteine metabolic process (GO:0006534) | 2.85041006 |
| 63 | iron ion import (GO:0097286) | 2.84658244 |
| 64 | negative regulation of fatty acid transport (GO:2000192) | 2.83491666 |
| 65 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.81873010 |
| 66 | negative regulation of lipid transport (GO:0032369) | 2.80626960 |
| 67 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.79293782 |
| 68 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.78648329 |
| 69 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.78595486 |
| 70 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.78595486 |
| 71 | aspartate family amino acid catabolic process (GO:0009068) | 2.78449650 |
| 72 | glutamate metabolic process (GO:0006536) | 2.78299175 |
| 73 | complement activation, alternative pathway (GO:0006957) | 2.76559589 |
| 74 | sulfur amino acid catabolic process (GO:0000098) | 2.75940824 |
| 75 | homocysteine metabolic process (GO:0050667) | 2.75239627 |
| 76 | positive regulation of fatty acid oxidation (GO:0046321) | 2.73575684 |
| 77 | plasma lipoprotein particle clearance (GO:0034381) | 2.73482135 |
| 78 | negative regulation of cell size (GO:0045792) | 2.72716696 |
| 79 | reverse cholesterol transport (GO:0043691) | 2.72275442 |
| 80 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.69874209 |
| 81 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.69791196 |
| 82 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.69459451 |
| 83 | regulation of protein activation cascade (GO:2000257) | 2.69198153 |
| 84 | nitrogen cycle metabolic process (GO:0071941) | 2.69176615 |
| 85 | endothelial cell chemotaxis (GO:0035767) | 2.68908348 |
| 86 | regulation of sequestering of triglyceride (GO:0010889) | 2.68794560 |
| 87 | aromatic amino acid family catabolic process (GO:0009074) | 2.68654392 |
| 88 | lymphangiogenesis (GO:0001946) | 2.68521399 |
| 89 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.65503751 |
| 90 | protein-lipid complex assembly (GO:0065005) | 2.65478637 |
| 91 | regulation of nuclease activity (GO:0032069) | 2.65096861 |
| 92 | artery development (GO:0060840) | 2.64560395 |
| 93 | regulation of cholesterol storage (GO:0010885) | 2.64445387 |
| 94 | regulation of fibrinolysis (GO:0051917) | 2.63857694 |
| 95 | growth hormone receptor signaling pathway (GO:0060396) | 2.63740834 |
| 96 | triglyceride homeostasis (GO:0070328) | 2.62644745 |
| 97 | acylglycerol homeostasis (GO:0055090) | 2.62644745 |
| 98 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.61232334 |
| 99 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.61104295 |
| 100 | phospholipid efflux (GO:0033700) | 2.60614797 |
| 101 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.60208893 |
| 102 | pharyngeal system development (GO:0060037) | 2.59829055 |
| 103 | maternal placenta development (GO:0001893) | 2.59654147 |
| 104 | cellular response to exogenous dsRNA (GO:0071360) | 2.59212321 |
| 105 | tricarboxylic acid metabolic process (GO:0072350) | 2.58787768 |
| 106 | regulation of fatty acid oxidation (GO:0046320) | 2.58087315 |
| 107 | regulation of alkaline phosphatase activity (GO:0010692) | 2.57501879 |
| 108 | plasma membrane repair (GO:0001778) | 2.56934883 |
| 109 | cell differentiation involved in embryonic placenta development (GO:0060706) | 2.56882404 |
| 110 | endocardial cushion development (GO:0003197) | 2.56469078 |
| 111 | glyoxylate metabolic process (GO:0046487) | 2.56322712 |
| 112 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.55380568 |
| 113 | amino-acid betaine metabolic process (GO:0006577) | 2.54913816 |
| 114 | regulation of complement activation (GO:0030449) | 2.53885354 |
| 115 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.52618946 |
| 116 | regulation of memory T cell differentiation (GO:0043380) | 2.52289544 |
| 117 | positive regulation of defense response to virus by host (GO:0002230) | 2.51515069 |
| 118 | plasma lipoprotein particle assembly (GO:0034377) | 2.51297179 |
| 119 | endoderm formation (GO:0001706) | 2.50661524 |
| 120 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.50329914 |
| 121 | lipoprotein metabolic process (GO:0042157) | 2.49910884 |
| 122 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.48360390 |
| 123 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.48068845 |
| 124 | ER-nucleus signaling pathway (GO:0006984) | 2.47806216 |
| 125 | inositol phosphate-mediated signaling (GO:0048016) | 2.47625223 |
| 126 | mesodermal cell differentiation (GO:0048333) | 2.46533614 |
| 127 | fatty acid homeostasis (GO:0055089) | 2.46270211 |
| 128 | fatty acid beta-oxidation (GO:0006635) | 2.46033469 |
| 129 | negative regulation of cell killing (GO:0031342) | 2.45982798 |
| 130 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.45982798 |
| 131 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.45941325 |
| 132 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.45664768 |
| 133 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.44817208 |
| 134 | negative regulation of sodium ion transport (GO:0010766) | 2.44642027 |
| 135 | cellular response to unfolded protein (GO:0034620) | 2.43701440 |
| 136 | sterol homeostasis (GO:0055092) | 2.43594571 |
| 137 | hormone catabolic process (GO:0042447) | 2.43349059 |
| 138 | cellular glucuronidation (GO:0052695) | 2.42552461 |
| 139 | response to lipoprotein particle (GO:0055094) | 2.41526531 |
| 140 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.41509040 |
| 141 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.41325992 |
| 142 | regulation of gamma-delta T cell activation (GO:0046643) | 2.41257193 |
| 143 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.41061342 |
| 144 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.41061342 |
| 145 | macromolecular complex remodeling (GO:0034367) | 2.40821655 |
| 146 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 2.40666069 |
| 147 | lung lobe morphogenesis (GO:0060463) | 2.40448607 |
| 148 | glycerophospholipid catabolic process (GO:0046475) | 2.40168459 |
| 149 | cornea development in camera-type eye (GO:0061303) | 2.40127735 |
| 150 | cellular response to lithium ion (GO:0071285) | 2.39785974 |
| 151 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.38446886 |
| 152 | regulation of action potential (GO:0098900) | 2.38351478 |
| 153 | cell-substrate junction assembly (GO:0007044) | 2.38269802 |
| 154 | regulation of histone deacetylation (GO:0031063) | 2.38022314 |
| 155 | cell adhesion mediated by integrin (GO:0033627) | 2.35899101 |
| 156 | positive regulation of glomerulus development (GO:0090193) | 2.35476068 |
| 157 | negative regulation of kidney development (GO:0090185) | 2.32752066 |
| 158 | regulation of water loss via skin (GO:0033561) | 2.30063881 |
| 159 | protein heterotrimerization (GO:0070208) | 2.26850457 |
| 160 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.25162472 |
| 161 | endocrine hormone secretion (GO:0060986) | 2.24931248 |
| 162 | regulation of establishment of cell polarity (GO:2000114) | 2.23563590 |
| 163 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.19647863 |
| 164 | regulation of receptor binding (GO:1900120) | 2.19234600 |
| 165 | lung secretory cell differentiation (GO:0061140) | 2.18001665 |
| 166 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.16322130 |
| 167 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.16073994 |
| 168 | regulation of glomerulus development (GO:0090192) | 2.14663969 |
| 169 | striated muscle atrophy (GO:0014891) | 2.14124660 |
| 170 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.13630004 |
| 171 | positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511) | 2.13054477 |
| 172 | sphingoid metabolic process (GO:0046519) | 2.12696826 |
| 173 | polarized epithelial cell differentiation (GO:0030859) | 2.11486763 |
| 174 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.11198524 |
| 175 | peristalsis (GO:0030432) | 2.11087113 |
| 176 | establishment of skin barrier (GO:0061436) | 2.10812432 |
| 177 | lung vasculature development (GO:0060426) | 2.10761055 |
| 178 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 2.10569518 |
| 179 | intestinal epithelial cell development (GO:0060576) | 2.07133317 |
| 180 | facial nerve structural organization (GO:0021612) | 2.07006617 |
| 181 | pericardium development (GO:0060039) | 2.06641767 |
| 182 | angiogenesis involved in wound healing (GO:0060055) | 2.06053787 |
| 183 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.05761078 |
| 184 | ovulation cycle (GO:0042698) | 2.05040191 |
| 185 | negative regulation of axon guidance (GO:1902668) | 2.04562831 |
| 186 | snRNA transcription (GO:0009301) | 2.04514201 |
| 187 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.04440788 |
| 188 | regulation of axon guidance (GO:1902667) | 2.04050655 |
| 189 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.03732421 |
| 190 | skin morphogenesis (GO:0043589) | 2.03155437 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.49512677 |
| 2 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 4.65753348 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.96220225 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.76558576 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.74519809 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.36839441 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.36175876 |
| 8 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.96670589 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.67532786 |
| 10 | AHR_22903824_ChIP-Seq_MCF-7_Human | 2.63974681 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.59265081 |
| 12 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.57099930 |
| 13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.52620050 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.46929703 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.36975443 |
| 16 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.34485704 |
| 17 | * MYC_22102868_ChIP-Seq_BL_Human | 2.30938559 |
| 18 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 2.21055249 |
| 19 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.05303398 |
| 20 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.05116530 |
| 21 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.03956592 |
| 22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.98421864 |
| 23 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.92229507 |
| 24 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.91552345 |
| 25 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.90512602 |
| 26 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.86536342 |
| 27 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.81755897 |
| 28 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.78374308 |
| 29 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.75536799 |
| 30 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.75360763 |
| 31 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.74946895 |
| 32 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.70527553 |
| 33 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.64870437 |
| 34 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.63858647 |
| 35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.62496330 |
| 36 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.61226448 |
| 37 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.59767429 |
| 38 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.57924285 |
| 39 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.56410053 |
| 40 | TP53_16413492_ChIP-PET_HCT116_Human | 1.56154120 |
| 41 | CJUN_26792858_Chip-Seq_BT549_Human | 1.56142884 |
| 42 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.54933462 |
| 43 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.54251177 |
| 44 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.53674993 |
| 45 | MAF_26560356_Chip-Seq_TH1_Human | 1.52677776 |
| 46 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.49139489 |
| 47 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.49139489 |
| 48 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.44964239 |
| 49 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.43579851 |
| 50 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.43241149 |
| 51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.42786508 |
| 52 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.42480197 |
| 53 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.42386567 |
| 54 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.40797181 |
| 55 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.40475831 |
| 56 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.40189889 |
| 57 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.39134809 |
| 58 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.39084730 |
| 59 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.39084730 |
| 60 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38910821 |
| 61 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.38787609 |
| 62 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.38114717 |
| 63 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.37443184 |
| 64 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.34963589 |
| 65 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.34931167 |
| 66 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.34379233 |
| 67 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.34118392 |
| 68 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.33311031 |
| 69 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.33156067 |
| 70 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.32993447 |
| 71 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.31805522 |
| 72 | KDM2B_26808549_Chip-Seq_K562_Human | 1.31589246 |
| 73 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.31101848 |
| 74 | GATA1_22025678_ChIP-Seq_K562_Human | 1.30782427 |
| 75 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.30328109 |
| 76 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.29972965 |
| 77 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.29792052 |
| 78 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.27883212 |
| 79 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.27661827 |
| 80 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.25460827 |
| 81 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.25200002 |
| 82 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.23900394 |
| 83 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.22649160 |
| 84 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.21938562 |
| 85 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.21087286 |
| 86 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.20628608 |
| 87 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.20107164 |
| 88 | GATA1_19941826_ChIP-Seq_K562_Human | 1.19290711 |
| 89 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.17575257 |
| 90 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.17237761 |
| 91 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.16630983 |
| 92 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.16582976 |
| 93 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.16390502 |
| 94 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.15658902 |
| 95 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14788099 |
| 96 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.14186161 |
| 97 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.13835213 |
| 98 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.13087173 |
| 99 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.13077175 |
| 100 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.12973342 |
| 101 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.12732395 |
| 102 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.10896200 |
| 103 | SPI1_23127762_ChIP-Seq_K562_Human | 1.10342991 |
| 104 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09735814 |
| 105 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.09475893 |
| 106 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.09026555 |
| 107 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.08610472 |
| 108 | MYB_26560356_Chip-Seq_TH1_Human | 1.08567691 |
| 109 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.08559381 |
| 110 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.07975225 |
| 111 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07352230 |
| 112 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.06558666 |
| 113 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.06014158 |
| 114 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.04630946 |
| 115 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.04265913 |
| 116 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.03734986 |
| 117 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.03555060 |
| 118 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.03396483 |
| 119 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.03356831 |
| 120 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03086060 |
| 121 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.02913969 |
| 122 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.02858659 |
| 123 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.02113242 |
| 124 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.02076110 |
| 125 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.01257866 |
| 126 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.01076226 |
| 127 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.00968808 |
| 128 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.00911864 |
| 129 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.00271294 |
| 130 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.99803030 |
| 131 | GATA2_19941826_ChIP-Seq_K562_Human | 0.99094508 |
| 132 | MYB_26560356_Chip-Seq_TH2_Human | 0.98401996 |
| 133 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.98045559 |
| 134 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.96957672 |
| 135 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.96912835 |
| 136 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.96337205 |
| 137 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.95939366 |
| 138 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.95678338 |
| 139 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.95412862 |
| 140 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.95192916 |
| 141 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.94837963 |
| 142 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.94832171 |
| 143 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.93156097 |
| 144 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.93129363 |
| 145 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.93120108 |
| 146 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.92991492 |
| 147 | STAT3_23295773_ChIP-Seq_U87_Human | 0.92378084 |
| 148 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.92071502 |
| 149 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.92036948 |
| 150 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.92036948 |
| 151 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.91863718 |
| 152 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.91403849 |
| 153 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.90991315 |
| 154 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90682684 |
| 155 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.90622552 |
| 156 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.90419788 |
| 157 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89884378 |
| 158 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.89357787 |
| 159 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.88801199 |
| 160 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.88355203 |
| 161 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.88287495 |
| 162 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87678229 |
| 163 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.87356776 |
| 164 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.87003976 |
| 165 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.85492879 |
| 166 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.84769803 |
| 167 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.84457627 |
| 168 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.84276048 |
| 169 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.84130957 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 4.45822831 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.87217777 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.76603279 |
| 4 | MP0003300_gastrointestinal_ulcer | 3.20555175 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.17475136 |
| 6 | MP0003646_muscle_fatigue | 3.00522141 |
| 7 | MP0005365_abnormal_bile_salt | 2.93370654 |
| 8 | MP0003252_abnormal_bile_duct | 2.76240926 |
| 9 | MP0009840_abnormal_foam_cell | 2.66743239 |
| 10 | MP0009053_abnormal_anal_canal | 2.66069088 |
| 11 | MP0002876_abnormal_thyroid_physiology | 2.59624161 |
| 12 | MP0000383_abnormal_hair_follicle | 2.48014992 |
| 13 | MP0010234_abnormal_vibrissa_follicle | 2.45573238 |
| 14 | MP0010352_gastrointestinal_tract_polyps | 2.38596822 |
| 15 | MP0003950_abnormal_plasma_membrane | 2.32464875 |
| 16 | MP0002837_dystrophic_cardiac_calcinosis | 2.27009375 |
| 17 | MP0003303_peritoneal_inflammation | 2.25156940 |
| 18 | MP0010329_abnormal_lipoprotein_level | 2.19509619 |
| 19 | MP0010678_abnormal_skin_adnexa | 2.11934762 |
| 20 | MP0001666_abnormal_nutrient_absorption | 2.10259193 |
| 21 | MP0002877_abnormal_melanocyte_morpholog | 2.07234395 |
| 22 | MP0000427_abnormal_hair_cycle | 2.04874969 |
| 23 | MP0008875_abnormal_xenobiotic_pharmacok | 2.01252991 |
| 24 | MP0004130_abnormal_muscle_cell | 1.92477631 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 1.91962228 |
| 26 | MP0009780_abnormal_chondrocyte_physiolo | 1.91605642 |
| 27 | MP0000467_abnormal_esophagus_morphology | 1.87494549 |
| 28 | MP0005083_abnormal_biliary_tract | 1.86725413 |
| 29 | MP0005646_abnormal_pituitary_gland | 1.85174579 |
| 30 | MP0003566_abnormal_cell_adhesion | 1.82333796 |
| 31 | MP0005076_abnormal_cell_differentiation | 1.72077793 |
| 32 | MP0005409_darkened_coat_color | 1.71964094 |
| 33 | MP0002138_abnormal_hepatobiliary_system | 1.68780596 |
| 34 | MP0008872_abnormal_physiological_respon | 1.68552232 |
| 35 | MP0004272_abnormal_basement_membrane | 1.67532199 |
| 36 | MP0000609_abnormal_liver_physiology | 1.65179154 |
| 37 | MP0002098_abnormal_vibrissa_morphology | 1.64997333 |
| 38 | MP0000579_abnormal_nail_morphology | 1.63347529 |
| 39 | MP0000537_abnormal_urethra_morphology | 1.62609937 |
| 40 | MP0004185_abnormal_adipocyte_glucose | 1.60962207 |
| 41 | MP0000538_abnormal_urinary_bladder | 1.60952859 |
| 42 | MP0005257_abnormal_intraocular_pressure | 1.58348335 |
| 43 | MP0008961_abnormal_basal_metabolism | 1.57949159 |
| 44 | MP0004233_abnormal_muscle_weight | 1.55923174 |
| 45 | MP0000534_abnormal_ureter_morphology | 1.46617807 |
| 46 | MP0003806_abnormal_nucleotide_metabolis | 1.45702652 |
| 47 | MP0001879_abnormal_lymphatic_vessel | 1.43726887 |
| 48 | MP0004510_myositis | 1.43319688 |
| 49 | MP0004084_abnormal_cardiac_muscle | 1.42578976 |
| 50 | MP0003942_abnormal_urinary_system | 1.38922086 |
| 51 | MP0002234_abnormal_pharynx_morphology | 1.38831257 |
| 52 | MP0003436_decreased_susceptibility_to | 1.38055042 |
| 53 | MP0000470_abnormal_stomach_morphology | 1.36464609 |
| 54 | MP0004885_abnormal_endolymph | 1.35395425 |
| 55 | MP0001348_abnormal_lacrimal_gland | 1.32809362 |
| 56 | MP0010771_integument_phenotype | 1.32717995 |
| 57 | MP0005666_abnormal_adipose_tissue | 1.32234155 |
| 58 | MP0002118_abnormal_lipid_homeostasis | 1.31095606 |
| 59 | MP0004087_abnormal_muscle_fiber | 1.31078007 |
| 60 | MP0008438_abnormal_cutaneous_collagen | 1.30729187 |
| 61 | MP0005275_abnormal_skin_tensile | 1.28331550 |
| 62 | MP0000230_abnormal_systemic_arterial | 1.27778302 |
| 63 | MP0004134_abnormal_chest_morphology | 1.27579139 |
| 64 | MP0001765_abnormal_ion_homeostasis | 1.26778495 |
| 65 | MP0002160_abnormal_reproductive_system | 1.22058576 |
| 66 | MP0003011_delayed_dark_adaptation | 1.22019656 |
| 67 | MP0000678_abnormal_parathyroid_gland | 1.21464669 |
| 68 | MP0009250_abnormal_appendicular_skeleto | 1.20524447 |
| 69 | MP0001661_extended_life_span | 1.20389427 |
| 70 | MP0001968_abnormal_touch/_nociception | 1.20229538 |
| 71 | MP0005330_cardiomyopathy | 1.20223270 |
| 72 | MP0005375_adipose_tissue_phenotype | 1.19562077 |
| 73 | MP0003879_abnormal_hair_cell | 1.19202413 |
| 74 | MP0004947_skin_inflammation | 1.19049597 |
| 75 | MP0001664_abnormal_digestion | 1.18913391 |
| 76 | MP0004858_abnormal_nervous_system | 1.18596119 |
| 77 | MP0005023_abnormal_wound_healing | 1.18329250 |
| 78 | MP0005332_abnormal_amino_acid | 1.17414207 |
| 79 | MP0000003_abnormal_adipose_tissue | 1.16506527 |
| 80 | MP0010630_abnormal_cardiac_muscle | 1.15630448 |
| 81 | MP0001944_abnormal_pancreas_morphology | 1.11721259 |
| 82 | MP0001216_abnormal_epidermal_layer | 1.11624154 |
| 83 | MP0005319_abnormal_enzyme/_coenzyme | 1.10980083 |
| 84 | MP0002166_altered_tumor_susceptibility | 1.10930652 |
| 85 | MP0004264_abnormal_extraembryonic_tissu | 1.08985263 |
| 86 | MP0001919_abnormal_reproductive_system | 1.08898107 |
| 87 | MP0003315_abnormal_perineum_morphology | 1.06827512 |
| 88 | MP0002269_muscular_atrophy | 1.06553815 |
| 89 | MP0010368_abnormal_lymphatic_system | 1.05626266 |
| 90 | MP0000013_abnormal_adipose_tissue | 1.05340605 |
| 91 | MP0003091_abnormal_cell_migration | 1.04586927 |
| 92 | MP0004381_abnormal_hair_follicle | 1.04565680 |
| 93 | MP0003959_abnormal_lean_body | 1.04558012 |
| 94 | MP0002909_abnormal_adrenal_gland | 1.04223686 |
| 95 | MP0005389_reproductive_system_phenotype | 1.03761429 |
| 96 | MP0002796_impaired_skin_barrier | 1.02518367 |
| 97 | MP0000685_abnormal_immune_system | 1.02226266 |
| 98 | MP0009278_abnormal_bone_marrow | 1.01894245 |
| 99 | MP0000747_muscle_weakness | 0.99941412 |
| 100 | MP0005503_abnormal_tendon_morphology | 0.99861535 |
| 101 | MP0009643_abnormal_urine_homeostasis | 0.99855097 |
| 102 | MP0000751_myopathy | 0.99077653 |
| 103 | MP0003936_abnormal_reproductive_system | 0.97048126 |
| 104 | MP0003279_aneurysm | 0.95977990 |
| 105 | MP0000377_abnormal_hair_follicle | 0.95971694 |
| 106 | MP0003183_abnormal_peptide_metabolism | 0.95625021 |
| 107 | MP0005167_abnormal_blood-brain_barrier | 0.94610819 |
| 108 | MP0010155_abnormal_intestine_physiology | 0.94265114 |
| 109 | MP0001756_abnormal_urination | 0.93668353 |
| 110 | MP0000767_abnormal_smooth_muscle | 0.92124632 |
| 111 | MP0000627_abnormal_mammary_gland | 0.91470768 |
| 112 | MP0003868_abnormal_feces_composition | 0.90852339 |
| 113 | MP0000604_amyloidosis | 0.90732815 |
| 114 | MP0000598_abnormal_liver_morphology | 0.90710413 |
| 115 | MP0001849_ear_inflammation | 0.89813162 |
| 116 | MP0003195_calcinosis | 0.89712431 |
| 117 | MP0003453_abnormal_keratinocyte_physiol | 0.89624603 |
| 118 | MP0004036_abnormal_muscle_relaxation | 0.87285762 |
| 119 | MP0010386_abnormal_urinary_bladder | 0.87175025 |
| 120 | MP0009384_cardiac_valve_regurgitation | 0.86865284 |
| 121 | MP0000613_abnormal_salivary_gland | 0.86396821 |
| 122 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.86090248 |
| 123 | MP0002078_abnormal_glucose_homeostasis | 0.86089826 |
| 124 | MP0005220_abnormal_exocrine_pancreas | 0.85817976 |
| 125 | MP0004145_abnormal_muscle_electrophysio | 0.85397778 |
| 126 | MP0004782_abnormal_surfactant_physiolog | 0.85034136 |
| 127 | MP0001533_abnormal_skeleton_physiology | 0.84985778 |
| 128 | MP0000163_abnormal_cartilage_morphology | 0.83702524 |
| 129 | MP0005166_decreased_susceptibility_to | 0.83183735 |
| 130 | MP0000733_abnormal_muscle_development | 0.82071018 |
| 131 | MP0001790_abnormal_immune_system | 0.82020490 |
| 132 | MP0005387_immune_system_phenotype | 0.82020490 |
| 133 | MP0005501_abnormal_skin_physiology | 0.81341973 |
| 134 | MP0000762_abnormal_tongue_morphology | 0.81319231 |
| 135 | MP0001544_abnormal_cardiovascular_syste | 0.80653612 |
| 136 | MP0005385_cardiovascular_system_phenoty | 0.80653612 |
| 137 | MP0006054_spinal_hemorrhage | 0.80572123 |
| 138 | MP0002089_abnormal_postnatal_growth/wei | 0.80322596 |
| 139 | MP0005670_abnormal_white_adipose | 0.80156086 |
| 140 | MP0003045_fibrosis | 0.79509227 |
| 141 | MP0001873_stomach_inflammation | 0.79261849 |
| 142 | MP0002693_abnormal_pancreas_physiology | 0.79102292 |
| 143 | MP0003283_abnormal_digestive_organ | 0.77865654 |
| 144 | MP0000367_abnormal_coat/_hair | 0.77012827 |
| 145 | MP0002972_abnormal_cardiac_muscle | 0.74260265 |
| 146 | MP0005334_abnormal_fat_pad | 0.74204481 |
| 147 | MP0002108_abnormal_muscle_morphology | 0.73334300 |
| 148 | MP0002933_joint_inflammation | 0.73127614 |
| 149 | MP0001502_abnormal_circadian_rhythm | 0.73115621 |
| 150 | MP0002735_abnormal_chemical_nociception | 0.72975413 |
| 151 | MP0002896_abnormal_bone_mineralization | 0.72883424 |
| 152 | MP0010307_abnormal_tumor_latency | 0.72447936 |
| 153 | MP0001270_distended_abdomen | 0.72345132 |
| 154 | MP0004043_abnormal_pH_regulation | 0.71595608 |
| 155 | MP0001845_abnormal_inflammatory_respons | 0.70867854 |
| 156 | MP0002254_reproductive_system_inflammat | 0.70716200 |
| 157 | MP0005058_abnormal_lysosome_morphology | 0.70581803 |
| 158 | MP0001958_emphysema | 0.69785092 |
| 159 | MP0005464_abnormal_platelet_physiology | 0.67930109 |
| 160 | MP0008775_abnormal_heart_ventricle | 0.66457475 |
| 161 | MP0002971_abnormal_brown_adipose | 0.66402659 |
| 162 | MP0000759_abnormal_skeletal_muscle | 0.66193118 |
| 163 | MP0005623_abnormal_meninges_morphology | 0.64703408 |
| 164 | MP0003075_altered_response_to | 0.64356783 |
| 165 | MP0001800_abnormal_humoral_immune | 0.64337617 |
| 166 | MP0009763_increased_sensitivity_to | 0.64008009 |
| 167 | MP0001853_heart_inflammation | 0.63334871 |
| 168 | MP0002060_abnormal_skin_morphology | 0.62342465 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Short 1st metacarpal (HP:0010034) | 4.04619796 |
| 2 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 4.04619796 |
| 3 | Deep venous thrombosis (HP:0002625) | 3.82700152 |
| 4 | Abnormality of the 1st metacarpal (HP:0010009) | 3.50193949 |
| 5 | Xanthomatosis (HP:0000991) | 3.39063618 |
| 6 | Intrahepatic cholestasis (HP:0001406) | 3.14400289 |
| 7 | Clumsiness (HP:0002312) | 3.09140795 |
| 8 | Genetic anticipation (HP:0003743) | 3.02962151 |
| 9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.94045143 |
| 10 | Right ventricular cardiomyopathy (HP:0011663) | 2.91208766 |
| 11 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.90587012 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 2.88204962 |
| 13 | Hypoglycemic coma (HP:0001325) | 2.85440290 |
| 14 | Concave nail (HP:0001598) | 2.84962270 |
| 15 | Follicular hyperkeratosis (HP:0007502) | 2.80985294 |
| 16 | Keratoconus (HP:0000563) | 2.80257912 |
| 17 | Increased corneal curvature (HP:0100692) | 2.80257912 |
| 18 | Exercise-induced muscle cramps (HP:0003710) | 2.72860583 |
| 19 | Hyporeflexia of lower limbs (HP:0002600) | 2.69027251 |
| 20 | Abnormality of the nasal septum (HP:0000419) | 2.68447628 |
| 21 | Cerebral aneurysm (HP:0004944) | 2.65723188 |
| 22 | Hyperventilation (HP:0002883) | 2.65575609 |
| 23 | Increased connective tissue (HP:0009025) | 2.64861975 |
| 24 | Myocardial infarction (HP:0001658) | 2.64362108 |
| 25 | Morphological abnormality of the middle ear (HP:0008609) | 2.64297409 |
| 26 | Hypobetalipoproteinemia (HP:0003563) | 2.60632261 |
| 27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.56181781 |
| 28 | Complement deficiency (HP:0004431) | 2.54437088 |
| 29 | Congenital stationary night blindness (HP:0007642) | 2.53152861 |
| 30 | Myoglobinuria (HP:0002913) | 2.52958487 |
| 31 | Lip pit (HP:0100267) | 2.50176598 |
| 32 | Radial bowing (HP:0002986) | 2.49819069 |
| 33 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.49468562 |
| 34 | Short hallux (HP:0010109) | 2.48113020 |
| 35 | Hypoalphalipoproteinemia (HP:0003233) | 2.46323485 |
| 36 | Hypoplasia of the odontoid process (HP:0003311) | 2.42348976 |
| 37 | Hypolipoproteinemia (HP:0010981) | 2.41326410 |
| 38 | Aneurysm (HP:0002617) | 2.40963527 |
| 39 | Ketosis (HP:0001946) | 2.39991233 |
| 40 | Hyperglycemia (HP:0003074) | 2.37973726 |
| 41 | Hyperlipoproteinemia (HP:0010980) | 2.36725965 |
| 42 | Mitral valve prolapse (HP:0001634) | 2.35530404 |
| 43 | Ketoacidosis (HP:0001993) | 2.35273620 |
| 44 | Skin nodule (HP:0200036) | 2.34828790 |
| 45 | Abnormality of the Achilles tendon (HP:0005109) | 2.32958465 |
| 46 | Short phalanx of the thumb (HP:0009660) | 2.32745908 |
| 47 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.31647043 |
| 48 | Exercise-induced myalgia (HP:0003738) | 2.30349424 |
| 49 | Protrusio acetabuli (HP:0003179) | 2.29383937 |
| 50 | Tented upper lip vermilion (HP:0010804) | 2.29261722 |
| 51 | Ventricular tachycardia (HP:0004756) | 2.29240995 |
| 52 | Hyperammonemia (HP:0001987) | 2.29177167 |
| 53 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.29060712 |
| 54 | Abnormality of alanine metabolism (HP:0010916) | 2.29060712 |
| 55 | Hyperalaninemia (HP:0003348) | 2.29060712 |
| 56 | Chorioretinal atrophy (HP:0000533) | 2.27146757 |
| 57 | Tubular atrophy (HP:0000092) | 2.26817626 |
| 58 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.26384411 |
| 59 | Atrophic scars (HP:0001075) | 2.26318687 |
| 60 | J-shaped sella turcica (HP:0002680) | 2.24180942 |
| 61 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.22457164 |
| 62 | Sudden death (HP:0001699) | 2.20415054 |
| 63 | Decreased subcutaneous fat (HP:0001002) | 2.19936808 |
| 64 | Esophageal varix (HP:0002040) | 2.19678928 |
| 65 | Fragile nails (HP:0001808) | 2.19589915 |
| 66 | Spastic diplegia (HP:0001264) | 2.18449382 |
| 67 | Fibular aplasia (HP:0002990) | 2.17289509 |
| 68 | Epidermoid cyst (HP:0200040) | 2.17116512 |
| 69 | Protruding tongue (HP:0010808) | 2.16907963 |
| 70 | Abnormality of the renal cortex (HP:0011035) | 2.15960099 |
| 71 | Large for gestational age (HP:0001520) | 2.15867607 |
| 72 | Aortic dissection (HP:0002647) | 2.15476301 |
| 73 | Abnormality of the intrinsic pathway (HP:0010989) | 2.14597530 |
| 74 | Achilles tendon contracture (HP:0001771) | 2.13859363 |
| 75 | Cardiovascular calcification (HP:0011915) | 2.13765530 |
| 76 | Vascular calcification (HP:0004934) | 2.11927384 |
| 77 | Abnormality of complement system (HP:0005339) | 2.11773059 |
| 78 | Shawl scrotum (HP:0000049) | 2.10001397 |
| 79 | Aortic aneurysm (HP:0004942) | 2.09956711 |
| 80 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.09904828 |
| 81 | Abnormality of the odontoid process (HP:0003310) | 2.09199271 |
| 82 | Alopecia of scalp (HP:0002293) | 2.08697884 |
| 83 | Back pain (HP:0003418) | 2.08283626 |
| 84 | Arterial tortuosity (HP:0005116) | 2.06571598 |
| 85 | Fragile skin (HP:0001030) | 2.05903484 |
| 86 | Bladder diverticulum (HP:0000015) | 2.05305752 |
| 87 | Abnormality of nail color (HP:0100643) | 2.04180537 |
| 88 | Lymphangioma (HP:0100764) | 2.03912573 |
| 89 | Dysmetric saccades (HP:0000641) | 2.03704232 |
| 90 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.03124708 |
| 91 | Hypoglycemic seizures (HP:0002173) | 2.02587893 |
| 92 | Amelogenesis imperfecta (HP:0000705) | 2.02468794 |
| 93 | Fused cervical vertebrae (HP:0002949) | 2.02086200 |
| 94 | Menorrhagia (HP:0000132) | 2.01490598 |
| 95 | Hyperglycinuria (HP:0003108) | 2.00201085 |
| 96 | Hydroxyprolinuria (HP:0003080) | 1.99674931 |
| 97 | Abnormality of proline metabolism (HP:0010907) | 1.99674931 |
| 98 | Oligodontia (HP:0000677) | 1.99168636 |
| 99 | Obstructive sleep apnea (HP:0002870) | 1.97240336 |
| 100 | Flat acetabular roof (HP:0003180) | 1.96860539 |
| 101 | Increased mean platelet volume (HP:0011877) | 1.95704125 |
| 102 | Pancreatic cysts (HP:0001737) | 1.95219572 |
| 103 | Asymmetric septal hypertrophy (HP:0001670) | 1.94639023 |
| 104 | Congenital sensorineural hearing impairment (HP:0008527) | 1.94241787 |
| 105 | Distal lower limb amyotrophy (HP:0008944) | 1.94224263 |
| 106 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.92665335 |
| 107 | Abnormality of glycine metabolism (HP:0010895) | 1.92665335 |
| 108 | Mitral stenosis (HP:0001718) | 1.91390822 |
| 109 | Hyperacusis (HP:0010780) | 1.91308899 |
| 110 | Bundle branch block (HP:0011710) | 1.90696230 |
| 111 | Abnormal foot bone ossification (HP:0010675) | 1.90599787 |
| 112 | Cheilitis (HP:0100825) | 1.90393351 |
| 113 | Sparse lateral eyebrow (HP:0005338) | 1.89963377 |
| 114 | Polycythemia (HP:0001901) | 1.89783264 |
| 115 | Vascular tortuosity (HP:0004948) | 1.88989953 |
| 116 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.88779373 |
| 117 | Natal tooth (HP:0000695) | 1.87588170 |
| 118 | Abnormal platelet volume (HP:0011876) | 1.86994559 |
| 119 | Difficulty running (HP:0009046) | 1.86249177 |
| 120 | Bowed forearm bones (HP:0003956) | 1.86149538 |
| 121 | Bowing of the arm (HP:0006488) | 1.86149538 |
| 122 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.85045359 |
| 123 | Short femoral neck (HP:0100864) | 1.83398965 |
| 124 | Upper limb amyotrophy (HP:0009129) | 1.83107302 |
| 125 | Distal upper limb amyotrophy (HP:0007149) | 1.83107302 |
| 126 | Long toe (HP:0010511) | 1.83083770 |
| 127 | Hamartoma of the eye (HP:0010568) | 1.82831515 |
| 128 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.82372278 |
| 129 | Tibial bowing (HP:0002982) | 1.82214737 |
| 130 | Milia (HP:0001056) | 1.82149527 |
| 131 | Dilatation of the ascending aorta (HP:0005111) | 1.81760814 |
| 132 | Soft skin (HP:0000977) | 1.81759691 |
| 133 | Increased density of long bones (HP:0006392) | 1.78625932 |
| 134 | Type II lissencephaly (HP:0007260) | 1.78513505 |
| 135 | Fat malabsorption (HP:0002630) | 1.78389448 |
| 136 | Hematochezia (HP:0002573) | 1.78135345 |
| 137 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.78132669 |
| 138 | Premature rupture of membranes (HP:0001788) | 1.77068859 |
| 139 | Severe muscular hypotonia (HP:0006829) | 1.76762408 |
| 140 | Peritonitis (HP:0002586) | 1.76653819 |
| 141 | Hypercholesterolemia (HP:0003124) | 1.76486564 |
| 142 | Abnormality of the renal collecting system (HP:0004742) | 1.76381738 |
| 143 | Resting tremor (HP:0002322) | 1.75852250 |
| 144 | Joint hemorrhage (HP:0005261) | 1.75143745 |
| 145 | Rhabdomyolysis (HP:0003201) | 1.75007566 |
| 146 | Difficulty climbing stairs (HP:0003551) | 1.74304332 |
| 147 | Macroorchidism (HP:0000053) | 1.73925023 |
| 148 | Abnormal cartilage morphology (HP:0002763) | 1.73810806 |
| 149 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.73169243 |
| 150 | Frequent falls (HP:0002359) | 1.72221211 |
| 151 | Pendular nystagmus (HP:0012043) | 1.72137462 |
| 152 | Gaze-evoked nystagmus (HP:0000640) | 1.72072346 |
| 153 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.71991285 |
| 154 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.71991285 |
| 155 | Hypoplasia of dental enamel (HP:0006297) | 1.70993285 |
| 156 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.70796504 |
| 157 | Decreased circulating renin level (HP:0003351) | 1.70732350 |
| 158 | Visceral angiomatosis (HP:0100761) | 1.70281228 |
| 159 | Subaortic stenosis (HP:0001682) | 1.69227257 |
| 160 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.69227257 |
| 161 | Atrioventricular block (HP:0001678) | 1.68840767 |
| 162 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.67213384 |
| 163 | Aplasia/hypoplasia of the femur (HP:0005613) | 1.67095584 |
| 164 | Broad metatarsal (HP:0001783) | 1.66567157 |
| 165 | Prolonged partial thromboplastin time (HP:0003645) | 1.66479997 |
| 166 | Conical tooth (HP:0000698) | 1.66107324 |
| 167 | Abnormality of purine metabolism (HP:0004352) | 1.65944838 |
| 168 | Ulnar bowing (HP:0003031) | 1.65914489 |
| 169 | Muscle fiber splitting (HP:0003555) | 1.65537693 |
| 170 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.65448840 |
| 171 | Plantar hyperkeratosis (HP:0007556) | 1.65251951 |
| 172 | Slender long bone (HP:0003100) | 1.64892872 |
| 173 | Spontaneous hematomas (HP:0007420) | 1.64417358 |
| 174 | Hand muscle atrophy (HP:0009130) | 1.63697326 |
| 175 | Striae distensae (HP:0001065) | 1.63348481 |
| 176 | Ovoid vertebral bodies (HP:0003300) | 1.62647396 |
| 177 | Furrowed tongue (HP:0000221) | 1.62596091 |
| 178 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.62588872 |
| 179 | Colitis (HP:0002583) | 1.62440739 |
| 180 | Rectal prolapse (HP:0002035) | 1.62400480 |
| 181 | Abnormality of the radial head (HP:0003995) | 1.62061613 |
| 182 | Abnormal tarsal ossification (HP:0008369) | 1.62054940 |
| 183 | Hypoplastic ischia (HP:0003175) | 1.61855122 |
| 184 | EMG: myopathic abnormalities (HP:0003458) | 1.59096145 |
| 185 | Hemangiomatosis (HP:0007461) | 1.58842749 |
| 186 | Patellar aplasia (HP:0006443) | 1.58617249 |
| 187 | Increased variability in muscle fiber diameter (HP:0003557) | 1.58139097 |
| 188 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 1.57350128 |
| 189 | Bulbous nose (HP:0000414) | 1.57141858 |
| 190 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 1.55801865 |
| 191 | Blue sclerae (HP:0000592) | 1.55362416 |
| 192 | Dysostosis multiplex (HP:0000943) | 1.54657662 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.74279997 |
| 2 | PKN2 | 4.09420901 |
| 3 | TTN | 3.53735097 |
| 4 | ERN1 | 3.52822686 |
| 5 | MAPKAPK3 | 3.14580324 |
| 6 | MAP3K10 | 2.70780237 |
| 7 | GRK1 | 2.51028596 |
| 8 | RIPK1 | 2.42031163 |
| 9 | WNK4 | 2.38225530 |
| 10 | PTK6 | 2.27356472 |
| 11 | EEF2K | 2.23391950 |
| 12 | ADRBK2 | 2.17237862 |
| 13 | MUSK | 2.07000887 |
| 14 | PRKD2 | 2.00965970 |
| 15 | SIK1 | 1.99822007 |
| 16 | FGFR4 | 1.92297285 |
| 17 | MAP2K3 | 1.88984061 |
| 18 | FRK | 1.79241976 |
| 19 | MAP4K1 | 1.78851273 |
| 20 | AKT3 | 1.72428835 |
| 21 | MAP3K7 | 1.65663726 |
| 22 | FGFR3 | 1.58784049 |
| 23 | PDGFRA | 1.57046979 |
| 24 | CDK12 | 1.48708594 |
| 25 | GRK6 | 1.45716738 |
| 26 | STK39 | 1.44415523 |
| 27 | TLK1 | 1.42853916 |
| 28 | DMPK | 1.40997836 |
| 29 | MAP2K1 | 1.40897204 |
| 30 | MAP3K3 | 1.40421427 |
| 31 | STK38 | 1.38215459 |
| 32 | JAK1 | 1.33164936 |
| 33 | BMPR1B | 1.33085020 |
| 34 | ADRBK1 | 1.32925956 |
| 35 | LRRK2 | 1.30013446 |
| 36 | LATS1 | 1.27537561 |
| 37 | EPHB1 | 1.27092639 |
| 38 | ALK | 1.24337143 |
| 39 | FLT3 | 1.23841132 |
| 40 | BCKDK | 1.18531074 |
| 41 | SCYL2 | 1.18187261 |
| 42 | LMTK2 | 1.17754576 |
| 43 | TAOK1 | 1.17515851 |
| 44 | CAMK1D | 1.15403379 |
| 45 | RET | 1.13889230 |
| 46 | PRKCH | 1.09936120 |
| 47 | PRKCI | 1.09650292 |
| 48 | STK10 | 1.09508926 |
| 49 | BMX | 1.03521780 |
| 50 | TYK2 | 1.03005662 |
| 51 | TAOK3 | 1.02754971 |
| 52 | MAP2K6 | 1.00953022 |
| 53 | PIK3CA | 1.00608680 |
| 54 | ZAP70 | 0.99745462 |
| 55 | PTK2B | 0.99175841 |
| 56 | ITK | 0.97705991 |
| 57 | JAK2 | 0.96946335 |
| 58 | MAP3K2 | 0.95575245 |
| 59 | TGFBR2 | 0.95138707 |
| 60 | MAP3K1 | 0.92647876 |
| 61 | RPS6KA6 | 0.92022777 |
| 62 | TBK1 | 0.90953946 |
| 63 | KSR2 | 0.90221599 |
| 64 | SMG1 | 0.88386536 |
| 65 | CAMK1G | 0.85755627 |
| 66 | MYLK | 0.83197261 |
| 67 | PTK2 | 0.83059165 |
| 68 | CDK6 | 0.82061499 |
| 69 | MTOR | 0.81691666 |
| 70 | ACVR1B | 0.81495022 |
| 71 | PDGFRB | 0.81086812 |
| 72 | STK24 | 0.79994526 |
| 73 | PAK3 | 0.78149646 |
| 74 | ILK | 0.74600700 |
| 75 | IRAK3 | 0.74212558 |
| 76 | IKBKB | 0.74005125 |
| 77 | MAP3K9 | 0.73675573 |
| 78 | CSK | 0.73053889 |
| 79 | MAP2K2 | 0.72928192 |
| 80 | IRAK1 | 0.71640831 |
| 81 | JAK3 | 0.71189108 |
| 82 | WNK1 | 0.69182185 |
| 83 | SIK2 | 0.68786417 |
| 84 | CAMKK1 | 0.68185317 |
| 85 | MAP3K14 | 0.68134277 |
| 86 | MAPKAPK5 | 0.68004265 |
| 87 | FGFR2 | 0.67827749 |
| 88 | EPHA3 | 0.67272890 |
| 89 | HCK | 0.64390578 |
| 90 | PRKD3 | 0.64188457 |
| 91 | FGFR1 | 0.64128319 |
| 92 | PINK1 | 0.61960477 |
| 93 | HIPK2 | 0.61858460 |
| 94 | SIK3 | 0.61487875 |
| 95 | CDK4 | 0.61143703 |
| 96 | CDC42BPA | 0.61011404 |
| 97 | PRKD1 | 0.60532545 |
| 98 | RPS6KL1 | 0.60077714 |
| 99 | RPS6KC1 | 0.60077714 |
| 100 | SGK3 | 0.59535944 |
| 101 | MAP3K8 | 0.59094214 |
| 102 | PRKG2 | 0.57616807 |
| 103 | DDR2 | 0.57400689 |
| 104 | PDK1 | 0.56860072 |
| 105 | MELK | 0.56660995 |
| 106 | STK3 | 0.55606065 |
| 107 | PHKG2 | 0.55118735 |
| 108 | PHKG1 | 0.55118735 |
| 109 | PAK2 | 0.54237098 |
| 110 | PDPK1 | 0.52581800 |
| 111 | TNK2 | 0.50890764 |
| 112 | PRKCE | 0.48821866 |
| 113 | STK11 | 0.48399451 |
| 114 | PRKAA1 | 0.48359200 |
| 115 | PRKAA2 | 0.47164146 |
| 116 | CHUK | 0.47145981 |
| 117 | CASK | 0.46494297 |
| 118 | CDK8 | 0.45525716 |
| 119 | RPS6KB2 | 0.45504629 |
| 120 | MAP3K5 | 0.44754521 |
| 121 | EIF2AK1 | 0.44675247 |
| 122 | NEK1 | 0.44090588 |
| 123 | CDK9 | 0.43592044 |
| 124 | INSRR | 0.43251713 |
| 125 | MAP2K4 | 0.42955206 |
| 126 | NEK9 | 0.42823193 |
| 127 | RPS6KB1 | 0.42339946 |
| 128 | MARK2 | 0.42194712 |
| 129 | LATS2 | 0.41346385 |
| 130 | MAPK11 | 0.41268936 |
| 131 | MAPKAPK2 | 0.41178822 |
| 132 | GSK3A | 0.40838779 |
| 133 | PRKCZ | 0.40326824 |
| 134 | PAK4 | 0.40101974 |
| 135 | ICK | 0.38807987 |
| 136 | PIM2 | 0.37945165 |
| 137 | MST1R | 0.37854102 |
| 138 | EPHB2 | 0.37807946 |
| 139 | SGK2 | 0.37434920 |
| 140 | MAP3K11 | 0.37352321 |
| 141 | MET | 0.36413014 |
| 142 | TRPM7 | 0.36132970 |
| 143 | TGFBR1 | 0.36041344 |
| 144 | EPHA2 | 0.35921783 |
| 145 | RPS6KA2 | 0.35793796 |
| 146 | BTK | 0.35306312 |
| 147 | CSF1R | 0.35034471 |
| 148 | PIK3CG | 0.34081015 |
| 149 | FER | 0.33517519 |
| 150 | MST4 | 0.33501534 |
| 151 | EGFR | 0.31519899 |
| 152 | CAMK4 | 0.31214359 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.75897059 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.43517355 |
| 3 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 3.31211820 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.73083054 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.36341865 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.18660436 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.12400680 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.09156036 |
| 9 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.04158545 |
| 10 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.96875821 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.85201277 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.83350451 |
| 13 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.80214331 |
| 14 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.64077256 |
| 15 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.63463164 |
| 16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.60795188 |
| 17 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.59666950 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.56631275 |
| 19 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.55466627 |
| 20 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.54926428 |
| 21 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.53038892 |
| 22 | Bile secretion_Homo sapiens_hsa04976 | 1.51830093 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.51445535 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.51061623 |
| 25 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.48384172 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.47499311 |
| 27 | Insulin resistance_Homo sapiens_hsa04931 | 1.45915002 |
| 28 | Phototransduction_Homo sapiens_hsa04744 | 1.45023475 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.37002307 |
| 30 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.33346012 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.32801192 |
| 32 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.32536546 |
| 33 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.31917416 |
| 34 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.28059885 |
| 35 | Melanoma_Homo sapiens_hsa05218 | 1.26275095 |
| 36 | Lysine degradation_Homo sapiens_hsa00310 | 1.25726096 |
| 37 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.25659031 |
| 38 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.20824222 |
| 39 | Carbon metabolism_Homo sapiens_hsa01200 | 1.17323499 |
| 40 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.16897003 |
| 41 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.16344057 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 1.12193398 |
| 43 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.12169089 |
| 44 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.10384842 |
| 45 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.10177220 |
| 46 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.07842557 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.06613567 |
| 48 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.03929815 |
| 49 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.03314756 |
| 50 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.01762238 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.00222614 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00152394 |
| 53 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.97363932 |
| 54 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.96941073 |
| 55 | Insulin secretion_Homo sapiens_hsa04911 | 0.96853116 |
| 56 | Circadian rhythm_Homo sapiens_hsa04710 | 0.95576198 |
| 57 | Prostate cancer_Homo sapiens_hsa05215 | 0.91875790 |
| 58 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.90954949 |
| 59 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.88558550 |
| 60 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.86119952 |
| 61 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.85786793 |
| 62 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.81413840 |
| 63 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.81346844 |
| 64 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.80794196 |
| 65 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.80782551 |
| 66 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.79377303 |
| 67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.79040972 |
| 68 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.78816264 |
| 69 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.78679466 |
| 70 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.78209562 |
| 71 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.77946170 |
| 72 | Long-term depression_Homo sapiens_hsa04730 | 0.77462144 |
| 73 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.76855222 |
| 74 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.76816803 |
| 75 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.76549951 |
| 76 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.75702539 |
| 77 | Focal adhesion_Homo sapiens_hsa04510 | 0.75199897 |
| 78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.74835846 |
| 79 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.74725439 |
| 80 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.74715447 |
| 81 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.74330968 |
| 82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.73494346 |
| 83 | Bladder cancer_Homo sapiens_hsa05219 | 0.73403115 |
| 84 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.73152801 |
| 85 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.73065307 |
| 86 | Adherens junction_Homo sapiens_hsa04520 | 0.72110080 |
| 87 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72000854 |
| 88 | Mineral absorption_Homo sapiens_hsa04978 | 0.71066811 |
| 89 | Prion diseases_Homo sapiens_hsa05020 | 0.69998213 |
| 90 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.69709631 |
| 91 | Peroxisome_Homo sapiens_hsa04146 | 0.69588826 |
| 92 | Amoebiasis_Homo sapiens_hsa05146 | 0.69552143 |
| 93 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.68990518 |
| 94 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.68430276 |
| 95 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.68304678 |
| 96 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.66704526 |
| 97 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66450927 |
| 98 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.66419896 |
| 99 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.66242183 |
| 100 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.66130789 |
| 101 | Salivary secretion_Homo sapiens_hsa04970 | 0.65981454 |
| 102 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.65577055 |
| 103 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.64786255 |
| 104 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.64289853 |
| 105 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.63811093 |
| 106 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.63778632 |
| 107 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.63079337 |
| 108 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.62580616 |
| 109 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.62199860 |
| 110 | Axon guidance_Homo sapiens_hsa04360 | 0.61888208 |
| 111 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.61265174 |
| 112 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.60699290 |
| 113 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59976658 |
| 114 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.59691921 |
| 115 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.59547614 |
| 116 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.58585002 |
| 117 | Circadian entrainment_Homo sapiens_hsa04713 | 0.58444316 |
| 118 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58069734 |
| 119 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57696878 |
| 120 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57543203 |
| 121 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.56856469 |
| 122 | Pathways in cancer_Homo sapiens_hsa05200 | 0.56698899 |
| 123 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56531811 |
| 124 | Leishmaniasis_Homo sapiens_hsa05140 | 0.56423582 |
| 125 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.55814127 |
| 126 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.55523328 |
| 127 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54744960 |
| 128 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.53472640 |
| 129 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53330209 |
| 130 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52933544 |
| 131 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52552430 |
| 132 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.52377047 |
| 133 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.52009410 |
| 134 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.51995770 |
| 135 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50970882 |
| 136 | Renin secretion_Homo sapiens_hsa04924 | 0.50864323 |
| 137 | Histidine metabolism_Homo sapiens_hsa00340 | 0.50212785 |
| 138 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.49354161 |
| 139 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.49091783 |
| 140 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49068747 |
| 141 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.48533021 |
| 142 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.48125077 |
| 143 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.46339434 |
| 144 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.45964901 |
| 145 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.45942490 |
| 146 | Platelet activation_Homo sapiens_hsa04611 | 0.45517379 |
| 147 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.45215150 |
| 148 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43117863 |
| 149 | Endometrial cancer_Homo sapiens_hsa05213 | 0.42914570 |
| 150 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.41004913 |
| 151 | Glioma_Homo sapiens_hsa05214 | 0.40324158 |
| 152 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.39893107 |
| 153 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.39003456 |
| 154 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.38159783 |
| 155 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.37754985 |
| 156 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.37525184 |
| 157 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.36975735 |

